Loading
Total declarations
Companies
▲ Purchases (39 ops.)
▼ Sales (13 ops.)
Latest filing published 23 Oct 2026 for Allogene Therapeutics, Inc., €43k.
Filing timeline
BuySaleGeoffrey M. Parker
Insider track record
Disclosed buys
39
Disclosed sells
13
Signal history
Closed purchases
Market purchases
39
Positive at T+90
20%
Median T+90
-10.0%
Based on 15 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +7.2%Entry US$13.56 · Close at T+90 US$14.54
- -42.1%Entry US$23.66 · Close at T+365 US$13.70
- -59.6%Entry US$26.29 · Close at T+365 US$10.61
- -60.9%Entry US$5.57 · Close at T+365 US$2.18
- -99.2%Entry US$0.72 · Close at T+365 US$0.01
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Geoffrey M. Parker: trading record in brief
Geoffrey M. Parker has mostly bought: 36 purchases worth EUR 6.3 million, or 75% of market trades, with a median of EUR 89,663. The three largest, all at Tricida, Inc., are from July 2, 2018 (EUR 979,203), November 18, 2019 (EUR 590,863) and May 11, 2020 (EUR 557,632). The 12 sales come to EUR 2.8 million, with a median of EUR 99,203, including two on March 5, 2021 at ChemoCentryx, Inc.: EUR 790,895 and EUR 622,519.
The record holds 100 filings published from January 11, 2016 to September 15, 2026, split between PERRIGO Co plc (32, Director), ChemoCentryx, Inc. (25, Director), Tricida, Inc. (19, Chief Fin. Officer and Sr. VP), Allogene Therapeutics, Inc. (10, CHIEF FINANCIAL OFFICER) and Better Therapeutics, Inc. (7, Director). It also includes 25 grants, 23 option exercises and 4 other filings.
The peak is 2019 with 16 filings, ahead of 2020 (15); 2026 has 4 so far. Six filings fall in the last twelve months, including one purchase and 2 sales.
At ChemoCentryx, Thomas J. Schall has 5 trades within 30 days of Parker's, Thomas A. Edwards 4, Markus J. Cappel and Pui San Kwan 3, in the same direction.
Companies and markets linked to Geoffrey M. Parker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations101 total
36,342 shares@ US$1.34Common StockSEC:0001491874-26-000005:0
1,263 shares@ US$13.660.0007% mcap0.4% of flowOrdinary SharesSEC:0001585364-26-000151:0
607 shares@ US$13.660.0004% mcap0.2% of flowOrdinary SharesSEC:0001585364-26-000151:1
7,305 shares@ US$10.840.0035% mcap3.1% of flowOrdinary SharesSEC:0001585364-26-000075:0
24,001 shares@ US$1.7647.2% of flowCommon StockSEC:0001737287-26-000007:0
7,500 shares@ US$14.184.3% of flowOrdinary SharesSEC:0001491874-25-000007:0
Canonical exit: 10 Feb 2026 (T+90)
36,744 shares@ US$1.256552.8% of flowCommon StockSEC:0001737287-25-000091:0
4,375 shares@ US$22.97084.0% of flowOrdinary SharesSEC:0001585364-25-000128:0
Canonical exit: 16 Nov 2025 (T+90)
4,754 shares@ US$26.012.5% of flowOrdinary SharesSEC:0001585364-25-000074:1
9,904 shares@ US$26.0110.7% of flowOrdinary SharesSEC:0001585364-25-000074:0
3,500 shares@ US$27.104.0% of flowOrdinary SharesSEC:0001585364-25-000058:0
Canonical exit: 10 Aug 2025 (T+90)
4,361 shares@ US$1.730.7% of flowCommon StockSEC:0001737287-25-000019:0
173,913 shares0Common StockSEC:0001737287-25-000008:0
36,404 shares@ US$2.849.3% of flowCommon StockSEC:0001737287-24-000065:0
344,828 shares@ US$2.9089.9% of flowCommon StockSEC:0001593968-24-000715:0
4,207 shares@ US$30.222.6% of flowOrdinary SharesSEC:0001585364-24-000090:1
8,764 shares@ US$30.2211.3% of flowOrdinary SharesSEC:0001585364-24-000090:0
190 shares@ US$3.5950.1% of flowCommon StockSEC:0001593968-24-000449:0
Canonical exit: 29 Apr 2024 (T+90)
29,400 shares0Common StockSEC:0001593968-24-000195:0
3,750 shares0Common StockSEC:0000950170-23-071958:0
400,000 shares0Common StockSEC:0001593968-23-001369:0
390,000 shares0Common StockSEC:0001593968-23-001369:1
685,025 shares@ US$0.729954.4% of flowCommon StockSEC:0000950170-23-035679:0
Canonical exit: 25 Oct 2023 (T+90)
10,000 shares@ US$33.063714.2% of flowOrdinary SharesSEC:0001585364-23-000106:0
Canonical exit: 11 Sept 2023 (T+90)
3,734 shares@ US$32.862.5% of flowOrdinary SharesSEC:0001585364-23-000096:1
25 of 101 declarations
